help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hafez, M. M.
Right arrow Articles by Ascoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hafez, M. M.
Right arrow Articles by Ascoli, M.

Endocrinology, Vol 127, 394-402, Copyright © 1990 by Endocrine Society


ARTICLES

Epidermal growth factor desensitizes the gonadotropin-responsive adenylyl cyclase in membranes isolated from MA-10 Leydig tumor cells and luteinized rat ovaries

MM Hafez and M Ascoli
Population Council, New York, New York 10021.

In a previous publication we showed that addition of mouse epidermal growth factor (mEGF) to MA-10 Leydig tumor cells or rat luteal cells leads to an attenuation of the elevated rate of cAMP accumulation provoked by subsequent addition of hCG. Those studies also suggested that this was due to a decrease in the hCG-activated adenylyl cyclase activity, but formal proof of this hypothesis was not presented. The experiments presented herein were conducted to investigate the mechanisms responsible for this phenomenon and show that our initial suggestion was correct, because we can show that mEGF attenuates the hCG-activated adenylyl cyclase in membranes from MA-10 cells or luteinized rat ovaries. More importantly, however, the establishment of a cell-free system in which mEGF attenuates adenylyl cyclase allows us to conduct detailed investigations on the molecular mechanisms that underly this phenomenon. Using this system we have been able to show that the ability of mEGF to attenuate adenylyl cyclase activity 1) is specific for the hCG-activated enzyme, since it cannot be detected when the enzyme is activated with other ligands, such as vasoactive intestinal peptide or isoproterenol; 2) does not appear to be due to a reduction in the activity of the catalytic subunit of adenylyl cyclase or the stimulatory GTP-binding protein (Gs), because mEGF does not affect the stimulation of adenylyl cyclase by other effectors, and it has little or no effect on the ability of Gs to restore isoproterenol sensitivity to the adenylyl cyclase of S49 cyc- membranes; and 3) optimal expression of the mEGF effect can only be obtained in the presence of ATP or GTP.


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
R S Bhaskaran and M Ascoli
The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses
J. Mol. Endocrinol., April 1, 2005; 34(2): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. L. G. Lamm, R. M. Rajagopalan-Gupta, and M. Hunzicker-Dunn
Epidermal Growth Factor-Induced Heterologous Desensitization of the Luteinizing Hormone/Choriogonadotopin Receptor in a Cell-Free Membrane Preparation Is Associated with the Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor
Endocrinology, January 1, 1999; 140(1): 29 - 36.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
P. C. Gentry,, G. W. Smith,, D. R. Leighr, B. Bao, and M. F. Smith
Ontogeny of Stem Cell Factor Receptor (c-kit) Messenger Ribonucleic Acid in the Ovine Corpus Luteum
Biol Reprod, October 1, 1998; 59(4): 983 - 990.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society